Ultragenyx Pharmaceutical Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
RARE on Nasdaq
Location
60 Leveroni Court, Novato, CA

Insiders trading volume in the past year

Ultragenyx Pharmaceutical Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Emil D. Kakkis President & CEO, Director $119M -$5.06M -4.09% Feb 28, 2025
Thomas Richard Kassberg Cbo & Evp $11.4M -$254K -2.18% Mar 1, 2025
Dennis Karl Huang Officer $4.92M Mar 1, 2025
John Richard Pinion Officer $4.65M -$608K -11.6% Mar 1, 2025
Howard Horn Chief Financial Officer $4.29M -$466K -9.8% Mar 6, 2025
Erik Harris EVP & Chief Commercial Officer $3.7M -$636K -14.7% Mar 1, 2025
Eric Crombez EVP and Chief Medical Officer $2.81M -$405K -12.6% Apr 21, 2025
Karah Parschauer EVP and Chief Legal Officer $2.28M -$745K -24.6% Sep 12, 2025
William Aliski Director $1.62M Jun 24, 2021
Theodore Alan Huizenga SVP, Chief Accounting Officer $1.47M -$45.2K -2.99% Sep 18, 2025
Mardi Dier CFO & Executive Vice President $1.4M Oct 14, 2022
Daniel G. Welch Director $1.24M May 15, 2025
Michael Narachi Director $1.24M May 15, 2025
Deborah Dunsire Director $1.17M May 15, 2025
Matthew K. Fust Director $985K May 15, 2025
Shehnaaz Suliman Director $985K May 15, 2025
Camille L. Bedrosian EVP and Chief Medical Officer $981K Mar 1, 2023
Amrit Ray Director $887K May 15, 2025
(Corsee) Sanders Corazon Director $574K -$89.9K -13.6% Jun 20, 2025
Lars Ekman Director $373K Jun 24, 2022

Recent Insider Transactions by Companies or Individuals for Ultragenyx Pharmaceutical Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.